Takeda and Protagonist Therapeutics have jointly submitted a NDA seeking approval from the US FDA for rusfertide to treat ...

The CDC now recommends 11 vaccines for routine administration in childhood, which it says better allows for “flexibility and ...

Arrowhead Pharmaceuticals has received authorisation from Health Canada for its siRNA medicine, Redemplo, for adults with FCS ...

Reporter Ross Law and editors Abigail Beaney and Robert Barrie reflect on a busy 2025, along with discusing forecasts for ...

According to the registration form, Aktis intends to use a large portion of the IPO proceeds on the two programmes. Around ...